Cargando…
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
PURPOSE: Interferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has both agonist and antagonist activities for IFN-β. However, its role regarding the clinical respon...
Autores principales: | Aliaga-Gaspar, Pablo, Hurtado-Guerrero, Isaac, Ciano-Petersen, Nicolas Lundahl, Urbaneja, Patricia, Brichette-Mieg, Isabel, Reyes, Virginia, Rodriguez-Bada, Jose Luis, Alvarez-Lafuente, Roberto, Arroyo, Rafael, Quintana, Ester, Ramió-Torrentà, Lluis, Alonso, Ana, Leyva, Laura, Fernández, Oscar, Oliver-Martos, Begoña |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716373/ https://www.ncbi.nlm.nih.gov/pubmed/34975865 http://dx.doi.org/10.3389/fimmu.2021.778204 |
Ejemplares similares
-
Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2020) -
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2023) -
Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2017) -
Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model
por: Zhao, Rong, et al.
Publicado: (2014) -
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia
por: Ejlerskov, Patrick, et al.
Publicado: (2015)